Universal Anti-Viral Vaccine for Healthy Elderly Adults

Clinical trial NCT04441047 · COMPLETED

Trial details

NCT number: NCT04441047
Sponsor: Mirror Biologics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Virus Diseases Pneumonia COVID-19 Respiratory Infection RSV Pneumonia Influenza, Human ARDS, Human

Start date: 2021-07-12
Primary completion: 2023-03-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.